This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.00677-07v1 81/17/9357    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ostrowski, M. Articles by Lopez, O. J. Search for Related Content PubMed PubMed Citation Articles by Ostrowski, M. Articles by Lopez, O. J.

The Early Protective Thymus-Independent Antibody Response to Foot-and-Mouth Disease Virus Is Mediated by Splenic CD9⁺ B Lymphocytes

Instituto de Virologia, Centro de Investigaciones en Ciencias Veterinarias, INTA-Castelar, Buenos Aires, Argentina,¹ Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina,² Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina,³ Department of Biology, Northern Michigan University, Marquette, Michigan⁴

Received 29 March 2007/ Accepted 31 May 2007

Infection of mice with cytopathic foot-and-mouth disease virus (FMDV) induces a rapid and specific thymus-independent (TI) neutralizing antibody response that promptly clears the virus. Herein, it is shown that FMDV-infected dendritic cells (DCs) directly stimulate splenic innate-like CD9⁺ B lymphocytes to rapidly (3 days) produce neutralizing anti-FMDV immunoglobulin M antibodies without T-lymphocyte collaboration. In contrast, neither follicular (CD9^–) B lymphocytes from the spleen nor B lymphocytes from lymph nodes efficiently respond to stimulation with FMDV-infected DCs. The production of these protective neutralizing antibodies is dependent on DC-derived interleukin-6 (IL-6) and on CD9⁺ cell-derived IL-10 secretion. In comparison, DCs loaded with UV-inactivated FMDV are significantly less efficient in directly stimulating B lymphocytes to secrete TI antibodies. A critical role of the spleen in the early production of anti-FMDV antibodies in infected mice was also demonstrated in vivo. Indeed, either splenectomy or functional disruption of the marginal zone of the spleen delays and reduces the magnitude of the TI anti-FMDV antibody response in infected mice. Together, these results indicate that in addition to virus localization, the FMDV-mediated modulation of DC functionality is a key parameter that collaborates in the induction of a rapid and protective TI antibody response against this virus.

Published ahead of print on 13 June 2007.